Foley Partner, Edward Polk, Jr. will be speaking on September 16, 2010 at the Practicing Law Institute (PLI) – Developments in Pharmaceutical and Biotech Patent Law 2010. Mr. Polk will be discussing “Recent Changes in Patent Prosecution Practice”. His discussion will include the following points:
- Changes to the USPTO count system
- What are the implications of changes to the USPTO count system for biotech & pharma prosecutors?
- How could the changes impact RCE practice?
- Changes to BPAI appeal practice
- How will PTO’s changes streamline BPAI appeal practice?
- How will changes impact appeals from TC 1600?
- Proposed changes to missing parts practice to allow for 12 month extension for provisional patent applications
- Do the proposed changes really provide a 12-month extension to the 12-month provisional application period?
- Can the proposed changes be used to extend patent term for pharmaceutical applications?
- In re Tanaka (BPAI)
- Is the addition of narrower claims a valid reason for filing a reissue if applicant does not also allege that one or more of the broader patent claims is overly broad?
- Can reissue applicant add specific species compound claims without also alleging broader genus claims are invalid?
For more information, please visit the Practicing Law Institute Web site.
Related Insights
July 25, 2025
Foley Viewpoints
Thorny Laws That ICHRA Vendors Should Consider, Part Three: FinTech Edition
We continue our series on the legal and regulatory challenges facing individual coverage health reimbursement arrangements (ICHRAs); this…
July 24, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
July 23, 2025
Foley Viewpoints
The One Big Beautiful Bill and Workplace Immigration Enforcement
The “One Big Beautiful Bill Act,” signed into law by President Trump on July 4, 2025, will fund government efforts to continue to…